Intravitreal ranibizumab for diabetic macular edema with prompt versus deferred laser treatment: 5-year randomized trial results

Ophthalmology

Volumn 122, Issue 2, 2015, Pages 375-381

  Elman, Michael J ^a   Ayala, Allison ^b   Bressler, Neil M ^c   Browning, David ^d   Flaxel, Christina J ^e   Glassman, Adam R ^b   Jampol, Lee M ^f   Stone, Thomas W ^g  

^a Elman Retina Group   (United States)

^b JAEB CENTER FOR HEALTH RESEARCH   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d Charlotte Eye Ear Nose and Throat Associates   (United States)

^e OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^f NORTHWESTERN UNIVERSITY   (United States)

^g Retina Associates of Kentucky   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RANIBIZUMAB; ANGIOGENESIS INHIBITOR; MONOCLONAL ANTIBODY; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ARTICLE; CONTROLLED STUDY; DIABETIC MACULAR EDEMA; HUMAN; LASER SURGERY; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RETINA MACULA LUTEA; TREATMENT OUTCOME; VISUAL ACUITY; VISUAL IMPAIRMENT; AGED; ANTAGONISTS AND INHIBITORS; CLINICAL TRIAL; DIABETIC RETINOPATHY; FEMALE; INTRAVITREAL DRUG ADMINISTRATION; LASER COAGULATION; MACULAR EDEMA; MALE; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PHYSIOLOGY;

AGED; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL, HUMANIZED; COMBINED MODALITY THERAPY; DIABETIC RETINOPATHY; FEMALE; HUMANS; INTRAVITREAL INJECTIONS; LASER COAGULATION; MACULAR EDEMA; MALE; MIDDLE AGED; RANIBIZUMAB; TREATMENT OUTCOME; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISUAL ACUITY;

EID: 84921555945     PISSN: 01616420     EISSN: 15494713     Source Type: Journal    
DOI: 10.1016/j.ophtha.2014.08.047     Document Type: Article

References (6)

1. Diabetic Retinopathy Clinical Research Network, M.J. Elman, L.P. Aiello, and R.W. Beck Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema Ophthalmology 117 2010 1064 1077
2. Diabetic Retinopathy Clinical Research Network, M.J. Elman, N.M. Bressler, and H. Qin Expanded 2-year follow-up of ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema Ophthalmology 118 2011 609 614
3. Diabetic Retinopathy Clinical Research Network, M.J. Elman, H. Qin, and L.P. Aiello Intravitreal ranibizumab for diabetic macular edema with prompt versus deferred laser treatment: three-year randomized trial results Ophthalmology 119 2012 2312 2318
4. G. Verbeke, and G. Molenberghs Inference for the Marginal Model. In: Linear Mixed Models for Longitudinal Data 2000 Springer New York 55 76 Springer Series in Statistics
5. Diabetic Retinopathy Clinical Research Network Writing Committee Reproducibility of spectral-domain optical coherence tomography retinal thickness measurements and conversion to equivalent time-domain metrics in diabetic macular edema JAMA Ophthalmol 132 2014 1113 1122
6. P. Mitchell, F. Bandello, U. Schmidt-Erfurth RESTORE Study Group The RESTORE Study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema Ophthalmology 118 2011 615 625